AHR: Aryl hydrocarbon receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Tapinarof | Approved | Aryl hydrocarbon receptor agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Psoriasis
- 0.61
- Psoriasis vulgaris
- 0.54
- Atopic eczema
- 0.54
- Retinitis pigmentosa 85
- 0.51
- Neurodegenerative disease
- 0.50
- Foveal hypoplasia 3
- 0.45
- Coffee consumption
- 0.43
- Alcohol drinking
- 0.39
- Leukemia
- 0.38
- Abnormal urine sodium concentration
- 0.36
- Nephrolithiasis
- 0.35
Drugs and mechanisms are from ChEMBL CHEMBL3201 (CC BY-SA 3.0). Gene name, function (UniProt P35869, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets